Phase II Trial of First-Line Durvalumab and Chemotherapy in Patients With Extra-Pulmonary Small Cell Carcinoma

Introduction: Prospective randomized trials are lacking in extensive-stage or metastatic extra-pulmonary small cell carcinoma (EPSCC). As a result, treatment for EPSCC is largely extrapolated from SCLC studies. Methods: This single-arm phase II trial enrolled patients with EPSCC to investigate the a...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Peey-Sei Kok, PhD, Bryan Chan, MMed (Clin Epi), Mason Aberoumand, MAppStat, Alison Zhang, PhD, Ken O’Byrne, MD, Subotheni Thavaneswaran, PhD, Frank Lin, PhD, Maya Kansara, PhD, Theresa Corpuz, BSc (Hons), Patrick Wheeler, BS, Robert John Simes, PhD, David Thomas, PhD, Chee Khoon Lee, PhD
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Elsevier 2026-07-01
Цуврал:	JTO Clinical and Research Reports
Нөхцлүүд:	Small cell Durvalumab Chemo-immunotherapy Extrapulmonary small cell carcinoma EPSCC
Онлайн хандалт:	http://www.sciencedirect.com/science/article/pii/S2666364326000652
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!